EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 20,394 shares, a decline of 76.6% from the April 30th total of 87,001 shares. Approximately 0.8% of the company’s shares are sold short. Based on an average trading volume of 53,985 shares, the short-interest ratio is presently 0.4 days.

EUDA Health Price Performance

Shares of EUDA Health stock traded down $0.71 on Friday, hitting $18.06. 3,762 shares of the company’s stock traded hands, compared to its average volume of 81,763. The firm’s 50-day moving average price is $11.39 and its two-hundred day moving average price is $27.91. The stock has a market capitalization of $54.00 million, a PE ratio of -7.53 and a beta of 0.56. EUDA Health has a one year low of $5.26 and a one year high of $86.00.

EUDA Health (NASDAQ:EUDA) last issued its earnings results on Tuesday, May 5th. The company reported ($0.44) EPS for the quarter, beating the consensus estimate of ($1.20) by $0.76. The business had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million. On average, analysts forecast that EUDA Health will post 1.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have commented on the stock. Zacks Research upgraded shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research report on Friday, May 8th. Weiss Ratings cut shares of EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research report on Friday, May 8th. Finally, Greenridge Global dropped their target price on shares of EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research report on Monday, March 9th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $55.00.

Institutional Trading of EUDA Health

An institutional investor recently raised its position in EUDA Health stock. Citadel Advisors LLC lifted its position in EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,631 shares of the company’s stock after buying an additional 16,321 shares during the period. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. 4.35% of the stock is currently owned by hedge funds and other institutional investors.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.